Autoregulation Zone Identification via Cerebral Oximetry Index

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing systems for monitoring autoregulation in patients are inefficient and unreliable, making it difficult to identify autoregulation zones and determine target blood pressures, which are crucial for maintaining optimal cerebral blood flow and preventing conditions like ischemia or hyperemia.

Innovation Solution

A system that uses blood pressure and oxygen saturation sensors, along with data clustering algorithms like k-means and Gaussian mixture models, to identify autoregulation zones and determine target blood pressures by processing signals from sensors to derive a cerebral oximetry index, facilitating efficient and reliable monitoring of autoregulation status.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If existing systems and methods are used to determine autoregulation status, then monitoring can be performed, but the determination is inefficient and unreliable

Engineering Contradiction:
Improveautoregulation status determination reliabilityVSAvoidmonitoring efficiency
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent segments the continuous physiological data into discrete autoregulation zones (lower impaired, intact, upper impaired) based on blood pressure thresholds. This segmentation allows for more reliable and efficient determination of autoregulation status by categorizing complex physiological states into distinct, manageable zones that can be systematically monitored and evaluated.

Inventive Principle:
Principle #1Segmentation

2Measurement precision

If complex data processing algorithms are implemented to improve monitoring accuracy, then measurement precision improves, but device complexity increases

Engineering Contradiction:
Improveautoregulation zone identification accuracyVSAvoiddata processing system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent introduces an intermediary processing layer that receives raw physiological data from sensors and transforms it into clinically meaningful autoregulation zone classifications. This intermediary system uses established blood pressure threshold criteria to bridge the gap between raw data and clinical interpretation, improving measurement precision while managing device complexity through standardized processing protocols.

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS10463292B2System and method for identifying autoregulation zones
Publication Date: 2019.11.05 COVIDIEN LP
  • US10463292B2 patent drawing
  • US10463292B2 patent drawing
  • US10463292B2 patent drawing

AI summary

A system configured to monitor autoregulation includes a medical sensor configured to be applied to a patient and to generate a regional oxygen saturation signal. The system includes a controller having a processor configured to receive the regional oxygen saturation signal and a blood pressure signal and to determine a cerebral oximetry index (COx) based on the blood pressure signal and the regional oxygen saturation signal. The processor is also configured to apply a data clustering algorithm to cluster COx data points over a range of blood pressures, identify a first cluster of COx data points that corresponds to an intact autoregulation zone for the patient, and provide a first output indicative of the intact autoregulation zone for the patient.